|Table of Contents|

Application of endorectal ultrasonography in rectal stromal tumor diagnosis and neoadjuvant therapy evaluation

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2022 04
Page:
697-700
Research Field:
Publishing date:

Info

Title:
Application of endorectal ultrasonography in rectal stromal tumor diagnosis and neoadjuvant therapy evaluation
Author(s):
LIU Hanyue1; ZHENG Bo1; CHEN Yuexin1; SHI Gang2
1.Department of Function,Huludao Central Hospital,Liaoning Huludao 125001,China；2.Department of Colorectal Surgery,Cancer Hospital of China Medical University,Liaoning Cancer Hospital ﹠Institute,Liaoning Shenyang 110042,China.
Keywords:
rectal stromal tumor; endorectal ultrasonography; imatinib mesylate tablets
PACS:
R735.3+7
DOI:
10.3969/j.issn.1672-4992.2022.04.028
Abstract:
Objective:To observe the value of endorectal ultrasonography in rectal stromal tumor diagnosis and neoadjuvant therapy evaluation.Methods:Forty-six patients form May 2015 to May 2020 diagnosed as submucosal tumor was differentiated by endorectal ultrasonography retrospectively.Pathological diagnosis was golden standard and the ultrasonic diagnosis efficiency was identified.Endorectal ultrasonic datas were observed in 17 rectal stromal patients and the value of endorectal ultrasonography in imatinib neoadjuvant therapy evaluation was identified.The relationship between pathological risk and ultrasonic datas was observed.Results:The coincidence rate,sensitivity and specialty of endorectal ultrasonography with pathological diagnosis was 89.13%,88.24%，89.66% respectively.Endorectal ultrasonography showed that 52.94% tumor was over 5 cm,76.47% tumor echo was low,88.24% tumor did not show cystic changes,76.47% tumor showed abundant vascular supply and 64.71% tumor showed intraluminal growth pattern.Neoadjuvant therapy reaction in 14 patients was evaluated with endorectal ultrasonography,partial response rate was 57.14%（8/14），stable disease rate was 42.86%（6/14）.Compared with pre-therapy,tumor diameter decreased（P＜0.01）,tumor echo decreased（P＜0.05），cystic change increased（P＜0.05）,abundance of blood flow decreased（P＜0.01）.The tumor was large in diameter and the risk was high（P＜0.01）.The blood supply of the tumor was rich and the risk was high（P＜0.05）.Conclusion:Endorectal ultrasonography possesses relatively high sensitivity and specialty,which can be used to carry on differential diagnosis and evaluate the neoadjuvant therapy reaction.

References:

[1] SHEN C,CHEN H,YIN R,et al.Clinicopathologic,surgical characteristics and survival outcomes of rectal gastrointestinal stromal tumors ［J］.Neoplasma,2015,62(4):610-617.
[2] FIORE M,RAUT CP,GRONCHI A.Are we allowed to limit surgical aggressiveness with small rectal gastrointestinal stromal tumors ［J］.Ann Surg Oncol,2017,24(5):1153-1156.
[3] YOON KJ,KIM NK,LEE KY,et al.Efficacy of imatinib mesylate neoadjuvant treatment for a locally advanced rectal gastrointestinal stromal tumor ［J］.J Korean Soc Coloproctol,2011,27(3):147-152.
[4] MACHLENKIN S,PINSK I,TULCHINSKY H,et al.The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour ［J］.Colorectal Dis,2011,13(10):1110-1115.
[5] KANE WJ,FRIEL CM.Diagnosis and treatment of rectal gastrointestinal stromal tumors［J］.Dis Colon Rectum,2019,62(5):537-540.
[6] REVHEIM ME,HOLE KH,BRULAND OS,et al.DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour ［J］.Acta Oncol,2011,50(1):148-150.
[7] CHANGCHIEN CR,WU MC,TASI WS,et al.Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining ［J］.Dis Colon Rectum,2004,47(11):1922-1929.
[8] ALDER LS,ELVER G,FOO FJ,et al.Giant rectal gastrointestinal stromal tumours:a diagnostic and therapeutic challenge ［J］.J Surg Case Rep,2013(12):28-42.
[9] COTE A,FLORIN FG,MOIS E,et al.The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy ［J］.Ann Ital Chir,2018,89(1):68-76.
[10] COTE A,GRAUR F,LEBOVICI A,et al.The accuracy of endorectal ultrasonography in rectal cancer staging ［J］.Clujul Med,2015,88(3):348-356.
[11] CHANG XY,MA ZQ,LI Y,et al.Rectal gastrointestinal stromal tumor:a clinical and pathologic analysis［J］.Chin J Pathol,2016,45(7):462-466.
[12] NS IJ,MOHAMMADI M,TZANIS D,et al.Quality of treatment and surgical approach for rectal gastrointestinal stromal tumour(GIST) in a large European cohort ［J］.Eur J Surg Oncol,2020,46(6):1124-1130.
[13] SANTOS FERNANDES G,CASTRO COTTI GC,FREITAS D,et al.Downstaging of a rectal gastrointestinal stromal tumor by neoadjuvant imatinib therapy allowing for a conservative surgical approach ［J］.Clinics(Sao Paulo),2009,64(8):819-821.
[14] YASUI M,TSUJINAKA T,MORI M,et al.Characteristics and prognosis of rectal gastrointestinal stromal tumors:an analysis of registry data ［J］.Surg Today,2017,47(10):1188-1194.

Memo

Memo:
辽宁省自然科学基金(编号：2019-MS-211)
Last Update: 1900-01-01